Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the art
Year: 2022
Type: review
Source: European Neuropsychopharmacology
Institutions: University of Münster, Universitat Autònoma de Barcelona, Centro de Investigación Biomédica en Red de Salud Mental, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, National Health Service, King's College London, South London and Maudsley NHS Foundation Trust, National Institute for Health and Care Research, Novartis (Switzerland), University Medical Center Hamburg-Eppendorf, Institute of Neuroimmunology and Multiple Sclerosis, Charité – Universitätsmedizin Berlin, Erasmus MC, The University of Melbourne, Florey Institute of Neuroscience and Mental Health, Imperial College London, University of Tartu
Language: English
Subfield: Applied Psychology
Field: Psychology
Domain: Social Sciences
Open Access status: bronze
OpenAlex ID: W4281649337
